Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2BO9

Human carboxypeptidase A4 in complex with human latexin.

Replaces:  2BK7
Summary for 2BO9
Entry DOI10.2210/pdb2bo9/pdb
Related2BOA
DescriptorCARBOXYPEPTIDASE A4, HUMAN LATEXIN, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... (8 entities in total)
Functional Keywordsmetallocarboxypeptidase, x-ray crystal structure, endogenous protein inhibitor, latexin, metalloprotease carboxypeptidase, hydrolase
Biological sourceHOMO SAPIENS (HUMAN)
More
Cellular locationSecreted : Q9UI42
Cytoplasm : Q9BS40
Total number of polymer chains4
Total formula weight123007.47
Authors
Pallares, I.,Bonet, R.,Garcia-Castellanos, R.,Ventura, S.,Aviles, F.X.,Vendrell, J.,Gomis-Rueth, F.X. (deposition date: 2005-04-08, release date: 2005-04-15, Last modification date: 2024-11-13)
Primary citationPallares, I.,Bonet, R.,Garcia-Castellanos, R.,Ventura, S.,Aviles, F.X.,Vendrell, J.,Gomis-Rueth, F.X.
Structure of Human Carboxypeptidase A4 with its Endogenous Protein Inhibitor, Latexin.
Proc.Natl.Acad.Sci.USA, 102:3978-, 2005
Cited by
PubMed Abstract: The only endogenous protein inhibitor known for metallocarboxypeptidases (MCPs) is latexin, a 25-kDa protein discovered in the rat brain. Latexin, alias endogenous carboxypeptidase inhibitor, inhibits human CPA4 (hCPA4), whose expression is induced in prostate cancer cells after treatment with histone deacetylase inhibitors. hCPA4 is a member of the A/B subfamily of MCPs and displays the characteristic alpha/beta-hydrolase fold. Human latexin consists of two topologically equivalent subdomains, reminiscent of cystatins, consisting of an alpha-helix enveloped by a curved beta-sheet. These subdomains are packed against each other through the helices and linked by a connecting segment encompassing a third alpha-helix. The enzyme is bound at the interface of these subdomains. The complex occludes a large contact surface but makes rather few contacts, despite a nanomolar inhibition constant. This low specificity explains the flexibility of latexin in inhibiting all vertebrate A/B MCPs tested, even across species barriers. In contrast, modeling studies reveal why the N/E subfamily of MCPs and invertebrate A/B MCPs are not inhibited. Major differences in the loop segments shaping the border of the funnel-like access to the protease active site impede complex formation with latexin. Several sequences ascribable to diverse tissues and organs have been identified in vertebrate genomes as being highly similar to latexin. They are proposed to constitute the latexin family of potential inhibitors. Because they are ubiquitous, latexins could represent for vertebrate A/B MCPs the counterparts of tissue inhibitors of metalloproteases for matrix metalloproteinases.
PubMed: 15738388
DOI: 10.1073/PNAS.0500678102
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.6 Å)
Structure validation

246704

PDB entries from 2025-12-24

PDB statisticsPDBj update infoContact PDBjnumon